Abstract
The development of needle-free injection originally stemmed from a general apprehension of needle injections, disease transmission by accidental needle-sticks, and the need for effective mass immunization. Naked DNA vaccines, as attractive and universal as they appear, have not produced robust immune responses in test systems. However, proof of principle for DNA vaccines has been validated with a number of vaccine candidates in a variety of test systems, and the concept of DNA vaccines as a generic platform for vaccines still remains viable and attractive. Many avenues are being explored to enhance the immunogenicity of DNA vaccines. The easiest and most straightforward approach that can be quickly transitioned to a clinical trial setting is vaccine delivery by a needle-free jet injector. This approach has shown much potential in a number of cases and should become the lead method for enhancing DNA vaccines. This approach requires no additional development, and with an expanding market and willingness from jet injector manufacturers to produce prefilled syringes, the technique should become feasible for larger phase II/phase III trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Henry, K. and Campbell, S. (1995) Needlestick/sharps injuries and HIV exposure among health care workers. National estimates based on a survey of U.S. hospitals. Minn. Med. 78, 41ā44.
Hingson, R. A., Davis, H. S., and Rosen, M. (1963) Clinical experience with one and a half million jet injections in parenteral therapy and in preventive medicine. Mil. Med. 128, 525ā528.
Hingson, R. A., Davis, H. S., and Brailey, R. F. (1957) Mass inoculation of the Salk polio vaccine with the multiple dose jet injector. GP 15, 94ā96.
Liu, M. A. (2003) DNA vaccines: a review . J. Intern. Med. 253, 402ā410.
Henke, A. (2002) DNA immunizationāa new chance in vaccine research? Med. Microbiol. Immunol. (Berl), 191, 187ā190.
Corr, M., von Damm, A., Lee, D. J., and Tighe, H. (1999) In vivo priming by DNA injection occurs predominantly by antigen transfer. J. Immunol. 163, 4721ā4727.
Roy, M. J., Wu, M. S., Barr, L. J., et al. (2000) Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19, 764ā778
Schrijver, R. S., Langedijk, J. P., Keil, G. M., et al. (1998) Comparison of DNA application methods to reduce BRSV shedding in cattle. Vaccine 16, 130ā134.
van Rooij, E. M, Haagmans, B. L., de Visser, Y. E., de Bruin, M. G., Boersma, W., and Bianchi, A. T. (1998) Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet. Immunol. Immunopathol. 66, 113ā126.
Lundholm, P., Asakura, Y., Hinkula, J., Lucht, E., and Wahren, B. (1999) Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA. Vaccine 17, 2036ā2042.
Anwer, K., Earle, K. A., Shi, M., et al. (1999) Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. . Pharm. Res. 16, 889ā895.
Manam, S., Ledwith, B. J., Barnum, A. B., et al. (2000) Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 43, 273ā281.
Davis, H. L., Michel, M. L., Mancini, M., Schleef, M., and Whalen, R. G. (1994) Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 12, 1503ā1509.
Aguiar, J. C., Hedstrom, R. C., Rogers, W. O., et al. (2001) Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine 20, 275ā280.
Rogers, W. O., Baird, J. K., Kumar, A., et al. (2001) Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect. Immun. 69, 5565ā5572.
Raviprakash, K., Ewing, D., Simmons, M., et al. (2003) Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology 315, 345ā352.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Raviprakash, K., Porter, K.R. (2006). Needle-Free Injection of DNA Vaccines: A Brief Overview and Methodology. In: Saltzman, W.M., Shen, H., Brandsma, J.L. (eds) DNA Vaccines. Methods in Molecular Medicineā¢, vol 127. Humana Press. https://doi.org/10.1385/1-59745-168-1:83
Download citation
DOI: https://doi.org/10.1385/1-59745-168-1:83
Publisher Name: Humana Press
Print ISBN: 978-1-58829-484-5
Online ISBN: 978-1-59745-168-0
eBook Packages: Springer Protocols